Skip to content
Preprint

A Modular Agentic Framework for Synthetically Constrained Multi-Objective Hit-to-Lead Optimization

Aug 2026 · 0 citations · 12 references
Computer Science Biology

TL;DR

SABLE (Synthetically-accessible Agentic Bayesian Ligand Exploration), an open-source framework that employs natural-language orchestration to guide chemical structure optimization, is presented.

Abstract

Hit-to-lead optimization requires iterative design of hit analogs across competing potency, selectivity, physicochemical, pharmacokinetic, safety, and synthetic constraints. We present SABLE (Synthetically-accessible Agentic Bayesian Ligand Exploration), an open-source framework that employs natural-language orchestration to guide chemical structure optimization. SABLE uses an LLM to interpret user-defined goals and route tasks, while specialized tools perform reaction-templated analog enumeration, physicochemical and ADMET property prediction, structure-based affinity scoring, and Bayesian optimization. The resulting workflow is a computational twin of the analytical and prioritization stages of the design-make-test-analyze cycle, providing provenance of each numerical output. Across single, and multi-objective optimization studies, SABLE enriches candidate sets for user-defined computational objectives while evaluating only a subset of the enumerated search space. Its modular architecture allows tools and characterization backends to be replaced by editing a simple config file, without modifying operational logic. SABLE provides an extensible decision-support framework for prioritizing synthetically constrained analogs in early-stage drug discovery.

View source

Similar papers

Open access Aug 2026

A multi-agent molecular optimization framework leads to a rapid-recovery intravenous anesthetic candidate with an improved safety margin

Lead optimization, the systematic refinement of therapeutic compounds through iterative structural modification, faces a dual challenge in modern drug discovery: navigating astronomically vast molecular design spaces while balancing conflicting demands on potency, pharmacokinetics, and safety. We present MASCOT (Multi-...

Zhe Xue, Wei Ai, Zhuang Miao et al. · 0 citations
Aug 2026

Systematic Benchmarking of AI-Based Molecular Generation Models for Structure-Based Drug Design

A state-aware functional classifier (SAFC) is developed that integrates molecular dynamics derived receptor ensembles, ensemble docking and protein ligand interaction graphs that provides dynamics-aware functional activity rankings for generated molecules that were partly complementary to docking, drug-likeness and syn...

H. Kumar, Zheng-Xiao Yang, Yankai Yu et al. · 0 citations
#small language model Open access Sep 2026

DDA: a traceable multi-agent framework for automated structure-based drug design

Results indicate that DDA provides a scalable, executable, and traceable computational framework that reduces manual coordination in structure-based automated drug discovery and delivers prioritized candidate sets with minimal human intervention.

Yu-Tao Yu, Si-Cheng Tian, Guo-Hua Wang et al. · 0 citations
Open access Sep 2026

A Unified 3D Generative Model for Synthesizable Structure-Based Drug Design

LDDM (Large Drug Discovery Model) is introduced, a generative framework that supports a range of drug discovery tasks, including constrained and unconstrained docking, fragment linking and growing, and de novo design, and a programmable design algorithm that enables accurate design of synthetically accessible compounds...

Ilia Igashov, Arne Schneuing, Adrian W. Dobbelstein et al. · 0 citations
#artificial intelligence Preprint Sep 2026

El Agente Potente: High-Throughput Agentic Atomistic Simulations

This work introduces El Agente Potente, an agentic system that combines typed execution graphs with a complementary coding mode for MLIPs-driven atomistic simulations, and establishes typed execution graphs and code-based workflow construction as complementary mechanisms for agentic scientific computing.

Tsz-Wai Ko, Jia-Ru Bai, Thomas Swanick et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.